Resource Library

Physician, Scientific Advisory And Industry Insights

Over the past 30 years, the median age of women giving birth in the US has risen from 27 to 30, the highest on record. With this demographic shift comes a higher prevalence of chronic conditions. That means both prescribers and the life sciences industry need visibility into the evolving safety profile of drugs and the health effects on both mothers and newborns.

In this webinar, experts share practical tips for proactive surveillance via pregnancy registries and outline several ways biopharmaceutical companies can use this information to both satisfy safety monitoring requirements and build patient support programs.